» Articles » PMID: 39275291

The Role of Vitamin D in Hematopoietic Stem Cell Transplantation: Implications for Graft-versus-Host Disease-A Narrative Review

Overview
Journal Nutrients
Date 2024 Sep 14
PMID 39275291
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction/aim: Vitamin D plays a crucial role in immune modulation, which may influence the development of graft-versus-host disease (GvHD) in patients undergoing hematopoietic stem cell transplantation (HSCT). This study aims to evaluate the impact of vitamin D levels and supplementation on the incidence of GvHD in HSCT patients.

Methods: A narrative review was conducted across PubMed/Medline, Cochrane Library, CINAHL, and Embase databases.

Results: The reviewed studies indicated widespread vitamin D deficiency among HSCT patients, with baseline levels ranging from 12.8 to 29.2 ng/mL. Supplementation protocols varied significantly, with dosages ranging from 1000 IU/day to 60,000 IU/week. Post-supplementation levels improved in some studies. Studies exploring the relationship between vitamin D and GvHD showed mixed results. Lower baseline vitamin D levels were associated with an increased risk of acute GvHD in some studies, while others found no significant correlation. However, a significant association between low levels of vitamin D and the incidence of chronic GvHD was observed.

Conclusion: Vitamin D deficiency is prevalent in HSCT patients and may influence the risk of developing chronic GvHD. Future research should focus on larger and more rigorous studies to determine the optimal role of vitamin D as an adjuvant therapy in the context of HSCT.

Citing Articles

A Systematic Review of Vitamin D Supplementation in Oncology: Chance of Science or Effectiveness?.

Afonso M, Capelas M, Pimenta N, Santos T, Makitie A, Ganhao-Arranhado S Nutrients. 2025; 17(4).

PMID: 40004963 PMC: 11858158. DOI: 10.3390/nu17040634.


Association Between Calcium Level, Bone Mineral Density, and Hip Fracture: Analysis Based on NHANES Data.

Wang X, Ai Z Healthcare (Basel). 2025; 13(4).

PMID: 39997231 PMC: 11855654. DOI: 10.3390/healthcare13040356.

References
1.
Ros-Soto J, Anthias C, Madrigal A, Snowden J . Vitamin D: is it important in haematopoietic stem cell transplantation? A review. Bone Marrow Transplant. 2018; 54(6):810-820. DOI: 10.1038/s41409-018-0377-0. View

2.
Arain A, Matthiesen C . Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population. Hematol Oncol Stem Cell Ther. 2018; 12(3):133-139. DOI: 10.1016/j.hemonc.2018.08.001. View

3.
Glotzbecker B, Ho V, Aldridge J, Kim H, Horowitz G, Ritz J . Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD. Bone Marrow Transplant. 2012; 48(4):593-7. DOI: 10.1038/bmt.2012.177. View

4.
Funke V, Moreira M, Vigorito A . Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation. Rev Assoc Med Bras (1992). 2016; 62 Suppl 1:44-50. DOI: 10.1590/1806-9282.62.suppl1.44. View

5.
Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G . Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023; 13(1):82. PMC: 10188596. DOI: 10.1038/s41408-023-00853-3. View